The global demand for Lomefloxacin Market is presumed to reach the valuation of nearly USD XX MN by 2026 from USD XX MN in 2019 with a CAGR of XX% under the study period of 2020 - 2026.
Lomefloxacin is a drug that belongs to an antibiotic group called fluoroquinolones. It is active against a broad range of gram-positive and gram-negative organisms. It is used to treat various bacterial infections such as bronchitis, escherichia coli infections, Klebsiella infections, proteus infections, pseudomonas infections, staphylococcal infections, streptococcal infections, and urinary tract infections. It is sold under various brand names: Decalogiflox, Lofloquin, Logiflox, Lomaday, Lomaxacin, Lomebact, Lomeflon, Lomeflox, among others.
Rising global burden of bacterial or mycobacterial infections is driving the growth of the market. Bacterial infections are common and life-threatening in patients. Bacteria, viruses, parasites and fungi that are resistant to drugs cause 700,000 deaths each year. By 2050, it could cause 10 million deaths annually. Lomexacin is effective for infection in many ways and has contributed in a positive way to bacterial infections. New approaches and better responses to clinical trials are propelling approvals for the drug. This is projected to create a new scalable path. Meanwhile, availability for other alternatives is estimated to hinder the growth to some extent.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of lomefloxacin.
The entire Lomefloxacin market has been sub-categorized into type and application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
This section covers regional segmentation which accentuates on current and future demand for lomefloxacin market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Lomefloxacin Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the lomefloxacin market include Pfizer, Nakoda Chemicals LTD, LGM Pharma, Merck, Norna Chemical. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources, Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.